Serko Limited — Director's Dealing 2020

Jul 1, 2020

==> picture [101 x 28] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and Name of listed issuer: Date this disclosure made: Date of last disclosure: Director or senior manager giving disclosure Full name(s): Name of listed issuer: Name of related body corporate (if applicable): Position held in listed issuer:

Serko Limited 2-Jul-20 26-Jun-14 Robert Clyde McConaghy Serko Limited Not applicable Director

Full name(s):	Full name(s):	Full name(s):
Name of listed issuer:
Name of related body corporate (if applicable):
Position held in listed issuer:
Summary of acquisition or disposal of relevant interest(excluding specified derivatives) Class of affected quoted financial products:
Class of affected quoted financial products:		Ordinary shares
Nature of the affected relevant interest(s):		Registered holder and beneficial owner
For that relevant interest-
Number held in class before acquisition or disposal:		0
Number held in class after acquisition or disposal:		1,091
Current registered holder(s):		Not applicable
Registered holder(s) once transfers are registered:		Robert Clyde McConaghy

Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:		1
Date of transaction:		1-Jul-20
Nature of transaction:		Issue of ordinary shares.
Name of any other party or parties to the transaction (if known):		Not applicable
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily converted into a cash value describe the consideration:		The Shares are being issued, in lieu of cash, in part consideration for service provided by Mr McConaghy in his role as a non-executive director of the Company, for the period 1 April 2020 to 30 June 2020, to a value (representing 15% of his director remuneration for this period) of NZ$3,587.75. This is intended to assist Serko's cashflow during the Covid- affected period.The issue price was NZ$3.29 per Ordinary Share, being the 5 day volume weighted average market price of Serko Limited’s ordinary shares on the NZX through to 30 June 2020
Number of financial products to which the transaction related:		1,091 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the followin details—
Whether relevant interests were acquired or disposed of during a closed period:		No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period:		Not applicable
Date of the prior written clearance (if any):		Not applicable

Summary of other relevant interests after acquisition or disposal: Class of quoted financial products: Nature of relevant interest:

Ordinary shares Registered holder and beneficial owner of shares by virtue of Mr McConagh being a trustee of the Portofino Trust and having the power to exercise a rig to vote attached to, and to dispose of, the shares.

Summary of other relevant interests after acquisition or disposal:	Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:		Ordinary shares
Nature of relevant interest:		Registered holder and beneficial owner of shares by virtue of Mr McConagh being a trustee of the Portofino Trust and having the power to exercise a rig to vote attached to, and to dispose of, the shares.
For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative: Details of derivative,-
		181,818 ordinary shares
		Robert Clyde McConaghy as Trustee of Portofino Trust
		Not applicable
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):		Not applicable
A statement as to whether the derivative is cash settled or physically settled:		Not applicable
Maturity date of the derivative (if any):		Not applicable

Expiry date of the derivative (if any): Not applicable The price's specified terms (if any): Not applicable Any other details needed to understand how the amount of the consideration payable under th Not applicable derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative: Not applicable If the director or senior manager is not a party to the derivative, the nature of the relevant Not applicable interest in the derivative:

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosu is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer:

Date of signature:

1-Jul-20